Previous studies have demonstrated that CARMA3 mediates the activation of G protein-coupled receptors and receptor tyrosine kinases (RTKs) in tumor pathogenesis 21 a, and its expression has also been linked to Nrf2 activation in pancreatic cancer 27. This evidence concerns the gene NTRK1 and neoplasm.